EcoDrugPlus

Cathepsin K

Ensembl ID : ENSBSLG00000020953
Gene Symbol: CTSK
1 Cross references
194 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSBSLG00000019131
Gene Symbol: CTSK
1 Cross references
194 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSBSLG00000018810
Gene Symbol: CTSK
1 Cross references
194 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSBSLG00000020057
Gene Symbol: CTSK
1 Cross references
194 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSBSLG00000020365
Gene Symbol: CTSK
1 Cross references
194 Possible Orthologues:

Cathepsin K-Like

Ensembl ID : ENSBSLG00000007966
Gene Symbol: LOC114843460
3 Cross references
223 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSBSLG00000007992
Gene Symbol: LOC114843549
3 Cross references
235 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSBSLG00000016866
Gene Symbol: CDC7
3 Cross references
209 Possible Orthologues:

Cellular Tumor Antigen P53-Like

Ensembl ID : ENSBSLG00000008708
Gene Symbol: LOC114860643
2 Cross references
207 Possible Orthologues:

Cellular Tumor Antigen P53-Like

Ensembl ID : ENSBSLG00000009891
Gene Symbol: LOC114850503
2 Cross references
207 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSBSLG00000009336
Gene Symbol: CHEK1
3 Cross references
179 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSBSLG00000003013
Gene Symbol: CCKAR
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).